Background We previously reported the 5-year results of the phase 3 IBCSG 23-01 trial
comparing disease-free survival in patients with breast cancer with one or more …

Background For patients with breast cancer and metastases in the sentinel nodes, axillary
dissection has been standard treatment. However, for patients with limited sentinel-node …

There is considerable interest in foregoing axillary dissection (AD) when the sentinel node
(SN) is positive in early breast cancer, particularly when involvement is minimal …

Background Trials evaluating the omission of completion axillary-lymph-node dissection in
patients with clinically node-negative breast cancer and sentinel-lymph-node metastases …

Background The need for further axillary treatment in patients with breast cancer with low-
volume sentinel node (SN) involvement (micrometastases or smaller) is controversial …

Importance The results of the American College of Surgeons Oncology Group Z0011
(ACOSOG Z0011) trial were first reported in 2005 with a median follow-up of 6.3 years …

Importance Recent data from clinical trials have challenged traditional thinking about axillary
surgery in patients with breast cancer. Objectives To summarize evidence regarding the role …

Context Sentinel lymph node dissection (SLND) accurately identifies nodal metastasis of
early breast cancer, but it is not clear whether further nodal dissection affects survival …

Objective: The impact of axillary treatment in daily practice on 5-year regional recurrence
rate in breast cancer patients with isolated tumor cells or micrometastases in the sentinel …

Background It has been suggested that selective sentinel node (SN) biopsy alone can be
used to manage early breast cancer, but definite evidence to support this notion is lacking …